Signaturefd LLC Raises Stake in Amedisys, Inc. (NASDAQ:AMED)

Signaturefd LLC raised its holdings in Amedisys, Inc. (NASDAQ:AMED) by 88.2% during the second quarter, HoldingsChannel reports. The firm owned 1,131 shares of the health services provider’s stock after buying an additional 530 shares during the period. Signaturefd LLC’s holdings in Amedisys were worth $104,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Alpine Associates Management Inc. grew its holdings in shares of Amedisys by 23.0% during the fourth quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock worth $120,830,000 after buying an additional 237,600 shares during the last quarter. Park West Asset Management LLC grew its stake in shares of Amedisys by 8.0% in the 4th quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock valued at $77,195,000 after purchasing an additional 60,350 shares during the last quarter. Water Island Capital LLC increased its holdings in shares of Amedisys by 185.0% in the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock valued at $67,559,000 after purchasing an additional 461,368 shares during the period. Calamos Advisors LLC lifted its holdings in shares of Amedisys by 11.6% during the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after purchasing an additional 41,220 shares during the period. Finally, Norges Bank purchased a new position in Amedisys in the 4th quarter valued at $34,032,000. 94.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on AMED shares. William Blair lowered shares of Amedisys from an “outperform” rating to a “market perform” rating in a research note on Monday, July 1st. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft downgraded Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price for the company. in a research note on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $100.67.

Amedisys Stock Down 0.5 %

Shares of NASDAQ AMED opened at $97.52 on Wednesday. The stock has a market capitalization of $3.19 billion, a price-to-earnings ratio of -152.38, a price-to-earnings-growth ratio of 1.92 and a beta of 0.79. Amedisys, Inc. has a 52 week low of $89.55 and a 52 week high of $98.95. The firm has a 50-day moving average price of $97.44 and a 200 day moving average price of $94.51. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.10. The company had revenue of $591.19 million during the quarter, compared to the consensus estimate of $579.34 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. Equities research analysts anticipate that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.